Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 577

Document Document Title
WO/2018/215318A1
The invention relates to heteroaromatic compounds, particularly for use in electronic devices. The invention further relates to a method for producing the compounds according to the invention and to electronic devices containing same.  
WO/2018/178338A1
The present invention relates to compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof. The invention further relates to the use of the compounds of Formula (I) as A2A inhibitors. The invention also relates to...  
WO/2018/019254A1
The present invention discloses a diphenyl ketone-based compound and an application thereof in an organo-electroluminescent device. The compound has the properties of limited intermolecular crystallization, limited clustering, and excell...  
WO/2017/219917A1
Provided in the present invention is a new method for preparing a trabectedin, using safracin B as the starting material and through a series of reactions synthesizing trabectedin. The method easily obtains raw materials, has fewer synth...  
WO/2017/213379A1
The present specification relates to an organic transistor comprising an organic semiconductor layer containing a compound and a gas sensor employing the same.  
WO/2017/151947A1
The present disclosure relates to 4-azapodophylotoxins compounds, pharmaceutical compositions comprising such compounds, kits, and methods for using such compounds or pharmaceutical compositions.  
WO/2017/147161A1
Described herein are compounds, compositions, and methods of their use for the treatment of dermatological disorders or conditions.  
WO/2017/134984A1
The invention provides a method for obtaining 2-methylspiro (1,3-oxathiolane-5,3') quinuclidine sulfate at a high isomer ratio (cis/trans) from 3-hydroxy-3-mercaptomethylquinuclidine without requiring fractionation of isomers or an isome...  
WO/2017/121444A1
Compounds of the formula (I) in which X1, X2, X3, X4, R1, R2, R3, Q and Y have the meanings indicated in Claim 1, are inhibitors of c-Kit kinase, and can be employed for the treatment of cancer.  
WO/2017/020429A1
A nonaqueous electrolyte for a high-voltage lithium-ion battery and a lithium-ion battery. The electrolyte comprises a nonaqueous organic solvent, a lithium salt, and a double-nitrite compound selected from the structural formula 1, n be...  
WO/2016/141563A1
The present invention aims to provide a novel alicyclic epoxide that is useful as a raw material of 2-hydroxyl-4-oxa-5-thia tricycle[4.2.1.03,7] nonane derivative. The alicyclic epoxide of the present invention is a compound represented ...  
WO/2016/131521A1
The present invention relates to spirobifluorene derivatives of formula (I), the use thereof in electronic devices, and methods for producing said derivatives.  
WO/2016/127924A1
The present invention relates to novel tricyclic compounds which can bind to FXR and act as modulators of the FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acce...  
WO/2016/106652A1
Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds of Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions comprising these compounds and their use in therapy. In particular, provided is th...  
WO/2016/106628A1
Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions comprising these compounds and their use in therapy. In particular, prov...  
WO/2016/096686A1
The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.  
WO/2016/022521A1
Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are liver X receptor modulators, and which are useful in the treatment of diseases and disorders assoc...  
WO/2015/147129A1
An organic transistor that has a semiconductor active layer containing a compound that can be represented by formula (1) and has a molecular weight of 3,000 or less exhibits high carrier mobility (X represents an oxygen, sulfur, selenium...  
WO/2015/141765A1
 The purpose of the present invention is to provide novel compounds useful in the production of salacinol and a method for producing these compounds, a method for producing salacinol, methods for protecting and deprotecting a diol grou...  
WO/2015/123385A1
Described herein are modified sugar, iminosugar and azasugar compounds and methods of making same. One or more of these modified compounds contain sulfates, sulfites, sulfamates and/or sulfonamides. Also described are pharmaceutical comp...  
WO/2015/050989A3
The compounds and salts of the present invention inhibit kinases, especially the anaplastic lymphoma kinase (ALK) and the HGF receptor tyrosine kinase (RTK) c-Met, and are useful for treating or ameliorating abnormal cell proliferative d...  
WO/2015/039348A1
The present invention relates to Tetracyclic Heterocycle Compounds of Formula (I) and pharmaceutically acceptable salts or prodrug thereof, wherein n, X, Y, Z, R1, R2, and R3 are as defined herein. The present invention also relates to c...  
WO/2014/206349A1
The present invention relates to an oxa-thia-bicyclo[3.2.1]octane derivative, a preparation method, and use of same, and particularly to an oxa-thia-bicyclo[3.2.1]octane derivative represented by the general formula (I) or a hydrate, a s...  
WO/2014/188091A1
The invention relates to a multilayer superoleophobic and/or superhydrophobic material comprising: on the one hand, a first constituent that is a conductive substrate or a substrate that has previously been rendered conductive (1): • t...  
WO/2014/129446A1
 The purpose of the present invention is to provide a streptavidin mutant having reduced affinity for natural biotin, and to provide a biotin alterant having high affinity for the streptavidin mutant having low affinity for natural bio...  
WO/2013/146356A1
A novel method for manufacturing an acrylic acid ester derivative capable of providing high resolution and having excellent lithography properties such as LWR when used as one unit of the polymer that is included in a photoresist composi...  
WO/2013/143597A1
A compound of formula (I) and its use as an inhibitor of one or more histone demethylase enzymes.  
WO/2013/146379A1
An acrylic acid ester derivative expressed by the general formula (1). In the formula, R1 represents a hydrogen atom or an alkyl group with 1 to 5 carbon atoms; and R2 represents a hydrogen atom, alkyl group with 1 to 5 carbon atoms, or ...  
WO/2013/141143A1
Provided is a novel photochromic compound with favorable durability wherein the color during coloring is an intermediate color (exhibits double peak properties), color intensity is high, and color fading is rapid. For example, a chromene...  
WO/2013/127267A1
Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment using such compounds.  
WO/2013/041811A1
The present invention relates to organic compounds, usable as ligands in the preparation of lanthanide complexes or of certain water-soluble transition metals, a method for preparation thereof, and the use of said organic compounds as fl...  
WO/2013/038374A1
The invention relates to a process for manufacturing the compound of formula 1-6 which is a synthetic intermediate commonly used in the preparation of antibiotic compounds, or for manufacturing salts of that compound. The invention furth...  
WO/2013/013765A1
The invention relates to novel compounds based on thieno[3,2-b]thiophene- 2,5-dione and/or furo[3,2-b]furan-2,5-dione or their thioketone derivatives, methods for their preparation and intermediates used therein, mixtures and formulation...  
WO/2013/010380A1
Provided are 6-5 membered fused pyridine ring compounds according to Formula (I) or pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising these compounds and their use in therapy. In particular, provided is th...  
WO/2012/176918A1
Specifically provided is a chromene compound represented by formula (1), which has a short fading half-life even at low temperatures in a common polymer solid matrix. (In formula (1), R1 represents a hydroxyl group or the like; each of R...  
WO/2012/169605A1
In the present invention, a polymer compound containing a constitutional unit represented by formula (1), formula (2), formula (3) or formula (4) can be used to produce an organic thin film solar cell having a high open end voltage. (In ...  
WO/2012/168241A1
The present invention provides substituted pyrazine compounds of the formula (I) or N-oxides or agriculturally suitable salts thereof, wherein the variables in the formula (I) are defined as in the description. Substituted pyrazines of f...  
WO/2012/168397A1
The present invention provides substituted pyridine compounds of the formula (I) or N-oxides or agriculturally suitable salts thereof, wherein the variables in the formula (I) are defined as in the description. Substituted pyridines of f...  
WO/2012/127472A1
The present invention describes processes for the synthesis of 2-(furan-2-yl)-7-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin- l-yl] ethyl]-7H-pyrazolo[ 4,3-e ][1,2,4]- triazolo[1,5c] pyrimidin-5-amine (Preladenant) represented by the struc...  
WO/2012/121414A1
The present invention provides a novel photochromic compound having superior durability, a rapid fading speed, and a high color-emission density, and wherein the color tone during color emission exhibits an intermediate color. The chrome...  
WO/2012/103113A1
Disclosed herein are compounds useful for treating a viral infection, such HCV.  
WO/2012/098952A1
Provided is a photoresist composition which comprises a polymer that contains a specific vinylsulfonic acid ester derivative as constituent units and which exhibits improved LWR and can yield a high-resolution pattern. The specific vinyl...  
WO/2012/085222A1
The present invention is directed to novel compounds of formula (I) and their use as anti-angiogenic agents and anti-cancer agents.  
WO/2012/043102A1
Provided are an acrylamide derivative that can serve as a structural unit of a polymer compound to be included in a photoresist composition, a polymer compound obtained by polymerizing starting material containing said acrylamide derivat...  
WO/2012/033019A1
Provided are: a novel acrylic ester derivative which can serve as a constituent unit in a high-molecular compound that is to be incorporated into a photoresist composition; a high-molecular compound obtained by polymerizing a raw materia...  
WO/2011/104183A1
Compounds of formula (I) wherein G1 represents together with the two ring atoms of the pyrimidine ring to which it is attached, a 5-to 6-membered aromatic heterocyclic ring system which contains one or two heteroatoms selected from the g...  
WO/2011/014973A3
Conformationally restricted, spatially defined 12-30 membered macrocyclic ring systems of formulae Ia and Ib are constituted by three distinct molecular parts: Template A, conformation Modulator B and Bridge C. These macrocycles Ia and I...  
WO/2010/116337A1
The invention relates to antibacterial compounds of formula I wherein R1 represents alkoxy; each of U and V represents CH and W represents CH or N, or U represents N, V represents CH and W represents N, or each of U and V represents N an...  
WO/2010/067332A1
The invention relates to antibacterial compounds of formula I wherein R1 represents alkoxy (notably methoxy); R2 represents H or F; each of R3, R4, R5 and R6 represents independently H or D; V represents CH and W represents CH or N or V ...  
WO/2010/045987A1
Bicyclic nitrogen containing compounds and their use as antibacterials (Formula I).  

Matches 1 - 50 out of 577